HEART TRANSPLANTATION - ADULT (HTX) -> HTX - Infectious Diseases Abstracts

485 - Recombinant Herpes Zoster Vaccine (RZV) after Heart Transplantation: A Single Center Experience

Presentation Number
485
Speakers
Session Name
MINI ORAL 12 - MINI ORAL SESSION: Infectious Diseases
Date
Thu, Apr 23, 2020
Time
06:15 PM - 07:15 PM
Authors
Audio Upload

Previous ePresentation
481 - Acute Infection Disrupts the Respiratory Microbiome of Lung Transplant Recipients

Next ePresentations
489 - Clinical Outcomes after Pediatric Lung Transplantation at Cystic Fibrosis Care Centers
491 - Tacrolimus Trough Variability- Predictors and Outcomes in Pediatric Heart Transplantation
493 - Gene Expression Profiling Scores (Allomap) Can Successfully Predict the Absence of Serious Rejection in a Pediatric Heart Transplant Population; Single Center Experience
495 - Health-Related Quality of Life Differs by Pre-Operative Implant Strategy from before through Mid-Term after Surgery: Findings from INTERMACS
496 - Advances in Driveline Technology Cures Some but Infects Others: Single Center's Experience with Driveline Infections in HeartMate 3 Patients
501 - Immune Checkpoint Inhibitors in Thoracic Transplant Recipients: A Registry Initiative
502 - Challenges for Expansion of Thoracic Transplant Clinical Pharmacy in Brazil: Comparison with U.S. Accredited Centers and Call for Action
503 - Safety of Traditionally Dosed Enoxaparin in Patients Supported with Left Ventricular Assist Devices
504 - Early Experience with Elimination of Aspirin from the Antithrombotic Regimen of Patients with a HeartMate IIITM Left Ventricular Assist Device
506 - Carfilzomib for Heart Transplant Desensitization